Dr. Andrew Y. Kee
Claim this profileLegacy Good Samaritan Hospital and Medical Center
Studies Lung Cancer
Studies Prostate Cancer
19 reported clinical trials
60 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage II
Stage I
2Prostate Cancer
Affiliated Hospitals
Clinical Trials Andrew Y. Kee is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
Stereotactic Radiosurgery vs. HA-WBRT + Memantine
for Brain Cancer
Stereotactic radiosurgery (SRS) is a commonly used treatment for brain tumors. It is a one-day (or in some cases two day), out-patient procedure during which a high dose of radiation is delivered to small spots in the brain while excluding the surrounding normal brain. Whole brain radiation therapy with hippocampal avoidance (HA-WBRT) is when radiation therapy is given to the whole brain, while trying to decrease the amount of radiation that is delivered to the area of the hippocampus. The hippocampus is a brain structure that is important for memory. Memantine is a drug that is given to help relieve symptoms that can be caused by WBRT, including problems with memory and other mental symptoms. Health Canada, the regulatory body that oversees the use of drugs in Canada, has not approved the sale or use of memantine in combination with WBRT to treat this kind of cancer, although they have allowed its use in this study.
Recruiting2 awards Phase 3
More about Andrew Y. Kee
Clinical Trial Related2 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Andrew Y. Kee has experience with
- Radiation Therapy
- Cisplatin
- Atezolizumab
- Fluorouracil
- Paclitaxel
- Intensity-Modulated Radiation Therapy
Breakdown of trials Andrew Y. Kee has run
Lung Cancer
Prostate Cancer
Prostate Adenocarcinoma
Glioblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Y. Kee specialize in?
Andrew Y. Kee focuses on Lung Cancer and Prostate Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage II.
Is Andrew Y. Kee currently recruiting for clinical trials?
Yes, Andrew Y. Kee is currently recruiting for 11 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Andrew Y. Kee has studied deeply?
Yes, Andrew Y. Kee has studied treatments such as Radiation Therapy, Cisplatin, Atezolizumab.
What is the best way to schedule an appointment with Andrew Y. Kee?
Apply for one of the trials that Andrew Y. Kee is conducting.
What is the office address of Andrew Y. Kee?
The office of Andrew Y. Kee is located at: Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon 97210 United States. This is the address for their practice at the Legacy Good Samaritan Hospital and Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.